Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. (PLX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PLX · as of Jun 8, 2026
Key Statistics
Explore Protalix BioTherapeutics, Inc. Data
plx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
Competitors & Peers
plx competitorsPLX
CDXS
CHRS
GNFT
IVVD
MDWDStock Performance
Full HistoryAbout Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. Established in 1993 and based in Hackensack, New Jersey, Protalix BioTherapeutics, Inc. is a biopharmaceutical company primarily focused on advancing and globally commercializing recombinant therapeut…
what is protalix biotherapeutics, inc. · plx stock overview · protalix biotherapeutics, inc. company profile · who is protalix biotherapeutics, inc. ceo · plx AMEX · protalix biotherapeutics, inc. headquarters · protalix biotherapeutics, inc. business segments
About Stock Overview & Key Data
Protalix BioTherapeutics, Inc. (PLX) is a Healthcare company in the Biotechnology industry, listed on AMEX since May 15, 1998. As of the latest trading session, PLX stock price is $1.96, with a market capitalization of $157.9M. The stock has returned +27.27% over the past 12 months and +8.89% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Protalix BioTherapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Protalix BioTherapeutics, Inc. reported revenue of $52.7M and net income of -$6.6M. For detailed data — including Protalix BioTherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Protalix BioTherapeutics, Inc. (PLX) stock price is $1.96. The stock is traded on AMEX under the ticker symbol PLX. The 52-week range is $1.32 – $3.19.